Skip to content

Premature Rupture of Membranes at 34 to 37 Weeks' Gestation

Premature Rupture of Membranes at 34 to 37 Weeks' Gestation :Active vs Conservative Management

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03689062
Enrollment
120
Registered
2018-09-28
Start date
2019-05-31
Completion date
2020-03-31
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Rupture of Membrane

Brief summary

Prelabour rupture of membrane is defined as rupture of membranes prior to the onset of labour. Approximately 8% of pregnant women at term experience PROM, but the decision as to how term PROM should be managed clinically remains controversial, and there is wide variation in practice with no clear consensus on what constitutes optimal treatment. Although for the majority of women labour will start spontaneously within 24 hours following term PROM, up to 4%of women will not experience spontaneous onset of labour within seven days.

Interventions

PROCEDUREinduction of labor

oxytocin intravenous drip

PROCEDUREfollow up

hospitalization and antibiotics

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Preterm premature rupture of membranes. * Singleton gestation. * Pregnant between 34 weeks 0 days to 36 weeks 6 days.

Exclusion criteria

* Non cephalic presentation. * fetal distress. * Labour on admission. * Medical or obstetric complications such as(suspected chorioamnionitis ,hypertensive disorders, diabetes mellitus , active genital herpes , placenta previa , infection, meconium stained amniotic fluid ,severe fetal anomalies).

Design outcomes

Primary

MeasureTime frameDescription
the percentage of patients with chorioamnionitis24 hoursClinical chorioamnionitis is defined in the absence of other causes of hyperpyrexia by a temprature of \>38 C with either uterine tenderness , leucocytosis , maternal or fetal tachycardia , or foul smelling vaginal discharge

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026